NBY Competitors & Alternatives
Compare NovaBay Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
NBY
Main Stock$1.95
Tradestie Score
43
Market Cap
$8.23M
Revenue Growth
-0.8%
Analyst Upside
-56.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.36
|
$133.50M | - | 31 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.61
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$29.54
|
$110.20M | - | 35 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.11
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.84
|
$67.94M | - | 52 | Compare |
|
SINT
SiNtx Technologies, Inc. Common Stock
|
$1.35
|
$11.23M | - | 52 | Compare |
|
SNGX
Soligenix, Inc. Common Stock
|
$0.32
|
$10.38M | - | 43 | Compare |
|
OGEN
Oragenics Inc.
|
$0.20
|
$5.86M | - | 53 | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
|
GHSI
GHSI
|
- | - | - | - | Compare |
More NBY Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry